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High Performance Protein Enrichment Using
Streptavidin Magnetic Beads
Lena Hornsten, Maria Björner, Ann Bergh,
Gunnar Glad, Therese Grane´r, Helena Hedlund,
Ulf Hellberg, Kristina Uhle´n
GE Healthcare Bio-Sciences AB, Uppsala, Sweden
The binding of streptavidin to biotin is one of the stron-
gest known non-covalent biological interactions and hence a
powerful tool used in affinity chromatography. Biomol-
ecules can easily be fused with biotins, to which immobilized
streptavidin ligands on chromatography matrices can bind.
The usage of magnetic beads for affinity based purifications
simplifies small-scale purifications and provides high flexi-
bility with scales ranging from l to ml.
In this study, we show that the magnetic bead medium
Streptavidin Mag Sepharose™ offers leading performance
concerning binding capacity and achieved purity. Binding
capacity of Streptavidin Mag Sepharose for biotinylated
rabbit monoclonal IgG was 1.7 mg/ml bead slurry. Immu-
noprecipitation of 7.5 g/ml transferrin in a background of
5 mg/ml E.coli protein showed a 420-fold enrichment.
Scaling up immuno-precipitation experiments 10 times or
changing sample concentration 100 times, resulted in equal
purity and recovery (%).
The characteristics of the Mag Sepharose beads are; sim-
plify handling by reducing the risk of beads sticking on tubes
and pipette tips. Moreover, the beads respond quickly to
magnetic fields resulting in rapid separation of the beads
from the sample, completed within seconds.
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Proteomics Profiling of Human Melanoma, Breast
Cancer, Glioblastoma, Lung carcinoma, Osteosarcoma
and Cervical Cancer Cell Lines
Vadiraja B. Bhat1, Christine Miller2
1Agilent Technologies Inc., 2Agilent Technologies Inc.
Most often, global proteomic analysis is performed using
one type of cell line. However, protein expression may differ
from cell line to cell line within a single organism. In this
study, we investigated over 22 different types of human cell
lines by 1D-LC-MS/MS analysis using nanoLC coupled to a
q-TOF mass spectrometer. 100g each of protein samples
from 22 different types (7 melanoma, 8 breast cancer, 4
glioblastoma, 1 non-small cell lung carcinoma, 1 osteosar-
coma, 1 cervical cancer) of human cancer cell lysates were
reduced, alkylated and trypsin digested. After drying, digests
were reconstituted in 0.1% formic acid for LC-MS analysis.
1-2g of tryptic peptides from different types of cancer cell
lysates were analyzed in triplicates on HPLC-Chip/ 6520 or
6550 QTOF Mass Spectrometer using 90 min gradient.
The data was analyzed and semi-quantified using Spectrum
Mill bioinformatics tool. In this study, we demonstrated a
label free 1D-LC-MS/MS approach for proteomics pheno-
typing of several different types of human cancer cell lines.
About 5000 unique human proteins and 50000 unique
peptides were identified in the preliminary analysis of about
22 different human cancer cell lines. Proteomic comparison
of melanoma and breast cancer cells showed about 30% of
the total proteins unique to each cell type and about 68% of
proteins were differentially expressed. Overall about 75%
of the total proteins were differentially expressed between
different types of cancer cell lines. In this large scale pro-
teomics profiling study we found that protein expression
between different types of cells varies significantly.
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IFNbeta-1b Treatment Alters the Composition of
Circulating B Cell Subsets and Leads to Changes in the
B Cell Cytokine Secretion Profile in an Ex-vivo
Stimulation Assay for Patients with Relapsing-
Remitting Multiple Sclerosis
Alan Bergeron, Daniel Mielcarz, Ph.D., John DeLong,
Kathleen Smith, Alexandra Heyn, Karen Mack,
Brant Oliver, Lloyd Kasper, M.D., Jacqueline Channon, Ph.D.
Dartmouth College
Recent studies provide strong evidence for a role for B
cells in the pathology of relapsing-remitting multiple sclero-
sis (RRMS). To explore the effect of IFNbeta-1b treatment
on B cell phenotype and function in these patients, blood
was drawn from 10 RRMS patients before treatment and
again 2 and 6 months after daily injections of IFNbeta-1b.
Cryopreserved PBMCs were thawed and stained with panels
of antibodies against B cell surface antigens. PBMCs were
also stimulated with CpG-B. Stimulated cell surface pheno-
type as well as intracellular IL10 and IL6 were determined by
10-parameter flow cytometry. PBMCs from age and gender
matched normal healthy donors were examined in parallel.
At baseline, RRMS patients have significantly increased
frequencies of naı¨ve B cells and decreased frequencies of
memory B cells when compared with healthy controls.
CpG-B-stimulated PBMCs from patients treated with IFN-
beta-1b show an increase in IL-10 production and a decrease
in IL-6 production by naı¨ve, memory and B1 cells (a recent-
ly-described subset of autoantibody producing cells that are
CD20CD27CD43). These changes in cytokine pro-
duction are indicative of a change from a pro- to an anti-
inflammatory phenotype. In addition, this treatment alters the
composition of circulating B cell subsets, leading to an increase
after six months in circulating naı¨ve B cells and a decrease in
both memory and B1 cells, both cell types of which are poten-
tially pathogenic in RRMS. Although the number of subjects in
this study was limited, these findings suggest that alterations in
B cell phenotype and function may be a mechanism by which
IFNbeta-1b reduces disease activity.
Study Supported by: Bayer HealthCare Pharmaceuticals Inc.
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A Novel Experimental Scheme to Fully Separate
Permethylated Glycans and Allow Online RP-LC-MS
with Simplified ESI-MS Analysis
Jesse Hines1, Shujuan Tao2, Ron Orlando3, Stacy Brown4
1Complex Carbohydrate Research Center, University of
Georgia, 2Department of Biochemistry and Molecular
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Biology, University of Georgia, 3Department of Chemistry,
University of Georgia, 4Department of Pharmaceutical
Sciences, East Tennessee State University
Permethylation of glycans is one of the steps used in
glycoprotein analysis. Typical LC-MS configurations in-
volve reverse-phase chromatography coupled online to
ESI-MS systems. Historically, reverse phase chromatogra-
phy has been unsuccessful in separating permethylated gly-
cans. The interactions between the hydrophobic stationary
phase and the glycans, which have similar monosaccharide
compositions, are not distinct enough to enable their re-
solved separation. Therefore, ion chromatography is com-
monly used to separated these modified glycans.
In this work the authors have discovered a method that for
the first time enables separation of permethylated glycans
using reverse-phase media and mass spectrometry compati-
ble mobile phases. The method, which involves heat activa-
tion in conjunction with use of small-particle size columns,
has been successful in resolving both isomeric and structur-
ally similar glycans. The results of this new separation tech-
nique are a significant improvement over ion chromatogra-
phy and allow the LC to be directly coupled to the mass
spectrometer for MS and MS/MS sequence analysis.
With electrospray ionization glycans and other large or-
ganic molecules greater than 2000 Da. are typically exhib-
ited as charged ions within an ion series. In addition glycans
can form multiple adducts resulting in complex spectra for
just a single glycan. We observed that glycans separated with
this new approach exhibited a very unusual behavior during
electrospray ionization resulting in singly charged ions for all
glycans even those with masses greater than 4000 Da. The
presence of a single ion for each glycan greatly simplifies
analysis of the mass spectra. In addition the lack of multiple-
charged species results in improved mass accuracy by obvi-
ating the need to perform deisotoping calculations that can
propagate mass errors.
These results and observations will be presented in the
poster. In addition this initial discovery has spurred other
research which builds on this technique using alternate
reverse-phase media for quantitation of glycans.
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Development of a Fast HPAE-PAD Sialic Acid Analysis
Method
Jeffrey Rohrer, Deanna Hurum
Thermo Fisher Scientific
Sialic acids are often determined in glycoprotein thera-
peutic products due to their critical role in product stability
and/or efficacy. These carbohydrates play roles in glycopro-
tein bioavailability, function, stability, and metabolism.
High-performance anion-exchange chromatography with
pulsed amperometric detection (HPAE-PAD) is a com-
monly used technique for accurate determinations of the
two most common sialic acids found on glycoprotein oligo-
saccharides, N-acetylneuraminic acid (Neu5Ac) and N-gly-
colylneuraminic acid (Neu5Gc). After releasing the sialic
acids either by acid hydrolysis or digestion with the enzyme
neuraminidase, this assay typically requires 20 to 30 min per
sample injection. With increasing demand to more quickly
screen samples from expression cell line and growth condi-
tion optimization experiments, shorter analysis times are
needed for all analyses, including sialic acid analysis. This
presentation describes the development of a five minute
HPAE-PAD assay for glycoprotein sialic acids after prior
acetic acid hydrolysis. Acetic acid hydrolysis was chosen over
other sialic acid release methods to eliminate the time re-
quired for sample lyophilization. In addition to measuring
the common analytical figures of merit including method
linearity, limits of detection, and intra- and inter-day repro-
ducibility, we also evaluated method accuracy and rugged-
ness. Five common sialylated glycoproteins with published
sialic acid content were assayed to evaluated accuracy and
the same samples were used for spiked recovery experiments.
Recoveries from the five glycoprotein hydrolyzate samples
ranged from 81-96% for Neu5Ac and 82-106% for
Neu5Gc, and the determined amounts agreed with pub-
lished values, both suggesting method accuracy. The
method proved to be rugged to column change and 1000
sample injections.
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Automated Glycan Structural Isomer Differentiation
Using Bioinformatics Tool
Gurmil Gendeh1, Julian Saba1, Amy Zumwalt1,
Ningombam Sanjib Meitei2, Arun Apte2, Rosa Viner1
1Thermo Fisher Scientific, 2Premier Biosoft
Mass spectrometry (MS) has emerged as a powerful tool
for the structural elucidation of glycans. The use of perm-
ethylaytion in combination with multistage fragmentation
(MSn) is a critical aspect for glycan structural characteriza-
tion. Only MSn truly characterizes a glycan structure as it
allows identification of branching patterns, linkages and
resolution of isobaric structures which are otherwise indis-
tinguishable in MS/MS spectra. However, MSn analysis is
complicated by large number of spectra generated for a
single structure. It is very common that one must acquire
MS6 or MS7 level of fragmentation to differentiate potential
glycan structural isomers. Here we present the use of a
bioinformatics tool (SimGlycan) for glycan structural iso-
mer differentiation from MSn data.
SimGlycan software was used in combination with MSn
and permethylation to differentiate structural isomers pres-
ent in ovalbumin glycans. The ion trap MS profile was
acquired for permethylated ovalbumin glycans and spe-
cific precursors were targeted for MSn to differentiate
structural isomers. Sequential MSn data were imported
into SimGlycan software and various structural isomers
of ovalbumin glycans were differentiated. SimGlycan dif-
ferentiated structural isomers were verified using manual
assignment and previously published data.
CORE MANAGEMENT METHODS
125
Methods for Tracking Core-contributed Publications
and Increasing Acknowledgment and Authorship
Compliance
Carol Lynn Curchoe
New York University Langone Medical Center
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